Pereira, C. S., Cunha, S. C. & Fernandes, J. O. Prevalent mycotoxins in animal feed: occurrence and analytical methods. Toxins 11, 290 (2019).
Wang, J. H., Tolosa, J., Wang, W. Y. & Yang, X. L. Mycotoxins and fungal toxins: current status and future perspectives. Toxins 17, 176 (2025).
Tittlemier, S. A. et al. Fusarium and alternaria mycotoxins present in Canadian wheat and durum harvest samples. Can. J. Plant Pathol. 41, 403–414 (2019).
Bianchini, A. et al. DON occurrence in grains: a North American perspective. Cereal Food World 60, 32–56 (2015).
Sumarah, M. W. The deoxynivalenol challenge. J. Agric. Food Chem. 70, 9619–9624 (2022).
Ganesan, A. R. et al. Distribution, toxicity, interactive effects, and detection of ochratoxin and deoxynivalenol in food: a review. Food Chem. 378, 131978 (2022).
Ntungwe, E. N., Tchana, A. N. & Abia, W. A. Mycotoxin management: exploring natural solutions for mycotoxin prevention and detoxification in food and feed. Mycotoxin Res. 40, 519–534 (2024).
Karabacak, M. et al. Some medicinal plants used in animal health in nakhchivan autonomous republic. Int. J. Vet. Sci. 14, 945–956 (2025).
Ghareeb, K., Awad, W. A., Böhm, J. & Zebeli, Q. Impacts of the feed contaminant deoxynivalenol on the intestine of monogastric animals: poultry and swine. J. Appl. Toxicol. 35, 327–337 (2015).
Pestka, J. J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 84, 663–679 (2010).
Pinto, A., De Pierri, C. R., Evangelista, A. G., Gomes, A. & Luciano, F. B. Deoxynivalenol: toxicology, degradation by bacteria, and phylogenetic analysis. Toxins 14, 90 (2022).
Alabi, O. M. et al. Data analytics-based evaluation of blood indices and adaptation of medicated and non-medicated broiler chickens under humid tropical conditions. Transl. Anim. Sci. 8, txae040 (2024).
Huff, W. E., Doerr, J. A., Hamilton, P. B. & Vesonder, R. F. Acute toxicity of vomitoxin (deoxynivalenol) in broiler chickens. Poult. Sci. 60, 1412–1414 (1981).
Deng, Y. et al. Deoxynivalenol: emerging toxic mechanisms and control strategies, current and future perspectives. J. Agric. Food Chem. 71, 10901–10915 (2023).
Liu, M. et al. Ferroptosis is involved in deoxynivalenol-induced intestinal damage in pigs. J. Anim. Sci. Biotechnol. 14, 29 (2023).
Guan, H. et al. Disorders of iron metabolism: a “sharp edge” of deoxynivalenol-induced hepatotoxicity. Metabolites 15, https://doi.org/10.3390/metabo15030165 (2025).
Sun, Y. et al. Toxicokinetics and metabolism of deoxynivalenol in animals and humans. Arch. Toxicol. 96, 2639–2654 (2022).
Yang, X. et al. Deoxynivalenol induces testicular ferroptosis by regulating the Nrf2/ system Xc-/GPX4 axis. Food Chem. Toxicol. 175, 113730 (2023).
Jiang, J. et al. 18β-glycyrrhetinic acid protects against deoxynivalenol-induced liver injury via modulating ferritinophagy and mitochondrial quality control. J. Hazard. Mater. 471, 134319 (2024).
Zhou, J. et al. Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR pathway to prevent cervical Cancer. J. Ethnopharmacol. 338, 119126 (2025).
Shafiq, A. et al. Impact of fusobacterium nucleatum infectiom on ferroptosis suppression, oxidative stress, and prognostic outcomes in esophageal squamous cell carcinoma. Agrobiol. Rec. ume 18, 96–104 (2024).
Cao, L., Fan, L., Zhao, C., Yin, S. & Hu, H. Role of ferroptosis in food-borne mycotoxin-induced toxicities. Apoptosis 29, 267–276 (2024).
Maremonti, F. et al. Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases. Cell Death Differ. 31, 1104–1112 (2024).
Ma, Y.-D. et al. Gallic acid and loganic acid attenuate amyloid-β oligomer-induced microglia damage via NF-КB signaling pathway. Neuropharmacology 263, 110215 (2025).
Cai, Y. et al. Gallic acid attenuates sepsis-induced liver injury through C/EBPβ-dependent MAPK signaling pathway. Mol. Nutr. Food Res 68, e2400123 (2024).
Yang, K. et al. Impact of gallic acid on gut health: focus on the gut microbiome, immune response, and mechanisms of action. Front. Immunol. 11, 580208 (2020).
Lin, Y. et al. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front. Immunol. 11, 580593 (2020).
Yu, L. et al. Gallic acid alleviates exercise-induced muscle damage by inhibiting mitochondrial oxidative stress and ferroptosis. J. Transl. Med. 23, 30 (2025).
Wang, L.-Y., Wu, M.-Y., Wu, Z.-Y. & Li, Y.-T. Econazolium-gallate-econazole: the first econazole salt cocrystal registers dual optimizations in both physicochemical properties and antifungal efficacy. J. Mol. Struct. 1347, 143355 (2025).
Tilley, J. E. N. et al. Efficacy of feed additives to reduce the effect of naturally occurring mycotoxins fed to turkey hen poults reared to 6 weeks of age. Poult. Sci. 96, 4236–4244 (2017).
Luo, S. et al. Comparative sensitivity of proliferative and differentiated intestinal epithelial cells to the food contaminant, deoxynivalenol. Environ. Pollut. 277, 116818 (2021).
Hu, H. et al. Forsythoside a protects against zearalenone-induced cell damage in chicken embryonic fibroblasts via mitigation of endoplasmic reticulum stress. Vet. Res. Commun. 48, 1659–1670 (2024).
Hernandez, R. & Brown, D. T. Growth and maintenance of chick embryo fibroblasts (CEF). Curr. Protoc. Microbiol. Appendix 4, 4i, https://doi.org/10.1002/9780471729259.mca04is17 (2010).
Jia, B. et al. Mycotoxin deoxynivalenol-induced intestinal flora disorders, dysfunction and organ damage in broilers and pigs. J. Hazard Mater. 451, 131172 (2023).
Ghadimi, M., Sharifi, S. D., Najafi, A. & Mohammadi, H. Gallic acid supplementation partially ameliorates reproductive aging in rooster breeders by improving semen quality, sperm kinetics, hormones, and antioxidant status. Poult. Sci. 103, 103842 (2024).
Yu, H. L. et al. Molecular mechanism underlying pathogenicity inhibition by chitosan in Cochliobolus Heterostrophus. J. Agric. Food Chem. 72, 3926–3936 (2024).
Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. Bmc Bioinforma. 18, 529 (2017).
Pavlíková, N. Caffeic acid and diseases-mechanisms of action. Int. J. Mol. Sci. 24, 588 (2022).
Zhao, Y., Jiang, C., Lu, J., Sun, Y. & Cui, Y. Research progress of proanthocyanidins and anthocyanidins. Phytother. Res. 37, 2552–2577 (2023).
Xiang, Z. et al. Dietary gallic acid as an antioxidant: a review of its food industry applications, health benefits, bioavailability, nano-delivery systems, and drug interactions. Food Res. Int. 180, 114068 (2024).
Bai, J. et al. Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomed. Pharmacother. 133, 110985 (2021).
Hanieh, H. et al. Activation of aryl hydrocarbon receptor signaling by gallic acid suppresses progression of human breast cancer in vitro and in vivo. Phytomedicine 96, 153817 (2022).
Hu, Q., Wang, T., Zhou, M., Xue, J. & Luo, Y. In vitro antioxidant-activity evaluation of gallic-acid-grafted chitosan conjugate synthesized by free-radical-induced grafting method. J. Agric. Food Chem. 64, 5893–5900 (2016).
Zhang, J. et al. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function. Phytomedicine 109, 154589 (2023).
Dänicke, S., Valenta, H. & Döll, S. On the toxicokinetics and the metabolism of deoxynivalenol (DON) in the pig. Arch. Anim. Nutr. 58, 169–180 (2004).
He, J. et al. Graveoline attenuates D-GalN/LPS-induced acute liver injury via inhibition of JAK1/STAT3 signaling pathway. Biomed. Pharmacother. 177, 117163 (2024).
Riaz, R. et al. Investigation of oxidative stress and antioxidative enzymes in erythrocytes and bone marrow of albino rats treated with different concentrations of copper ferrite nanoparticles. Int. J. Agricult. Biosci. 14, 1035–1041 (2025).
Jiang, X. J., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Bio. 22, 266–282 (2021).
Jiang, J., Ruan, Y., Liu, X., Ma, J. & Chen, H. Ferritinophagy is critical for deoxynivalenol-induced liver injury in mice. J. Agric. Food Chem. 72, 6660–6671 (2024).
Shao, J., Bai, Z., Zhang, L. & Zhang, F. Ferrostatin-1 alleviates tissue and cell damage in diabetic retinopathy by improving the antioxidant capacity of the Xc-GPX4 system. Cell Death Discov. 8, 426 (2022).
Fang, Y. et al. Inhibiting ferroptosis through disrupting the NCOA4–FTH1 interaction: a new mechanism of action. ACS Cent. Sci. 7, 980–989 (2021).
Candelaria, P. V., Leoh, L. S., Penichet, M. L. & Daniels-Wells, T. R. Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents. Front. Immunol. 12, 607692 (2021).
Mansuer, M., Zhou, L., Wang, C., Gao, L. & Jiang, Y. Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance. Cell Death Dis. 15, 522 (2024).
Kuang, F., Liu, J., Tang, D. & Kang, R. Oxidative damage and antioxidant defense in ferroptosis. Front. Cell Dev. Biol. 8, 586578 (2020).
Yang, R. et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 Axis. Phytomedicine 122, 155135 (2024).
Yuan, Z. et al. Targeting NQO1 induces ferroptosis and triggers anti-tumor Immunity in Immunotherapy-resistant KEAP1-deficient cancers. Drug Resist. Updates 77, 101160 (2024).
Ma, W. et al. piR-16404 drives ferroptotic liver injury via CASTOR1/mTORC1/GPX4 dysregulation in HepG2 cells and mice: a novel toxicity mechanism of N, N-dimethylformamide. Arch. Toxicol. https://doi.org/10.1007/s00204-025-04198-7 (2025).
Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173–184 (2016).
Fan, Z. et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6, e371 (2017).
Tian, R. et al. Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: recent progress and future prospects. Phytomedicine 136, 156342 (2025).
Zhou, D. et al. Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation. Phytomedicine 106, 154429 (2022).
Hu, P. et al. Lactoferrin relieves deoxynivalenol-induced oxidative stress and inflammatory response by modulating the Nrf2/MAPK pathways in the liver. J. Agric. Food Chem. 71, 8182–8191 (2023).
Hu, Q. et al. β-caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats. Phytomedicine 102, 154112 (2022).
Song, C., Huang, L., Li, D. & Zhao, X. Artemisinin alleviates alcohol-induced cardiotoxicity by inhibiting ferroptosis via the Nrf2/NQO1 pathway in vivo and in vitro. J. Agric. Food Chem. 73, 12940–12948 (2025).
Badr, A. M., El-Orabi, N. F. & Ali, R. A. The implication of the crosstalk of Nrf2 with NOXs, and HMGB1 in ethanol-induced gastric ulcer: potential protective effect is afforded by raspberry ketone. PLoS ONE 14, e0220548 (2019).
Zhang, L. et al. Neferine ameliorates severe acute pancreatitis-associated intestinal injury by promoting NRF2-mediated ferroptosis. Int. J. Biol. Sci. 21, 3247–3261 (2025).
Anandhan, A. et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci. Adv. 9, eade9585 (2023).
Kerins, M. J. & Ooi, A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid. Redox Signal. 29, 1756–1773 (2018).
Sbodio, J. I., Snyder, S. H. & Paul, B. D. Regulators of the transsulfuration pathway. Br. J. Pharm. 176, 583–593 (2019).
Wei, G. et al. Targeting hypoxia-induced CBS expression inhibits breast cancer stem cells through the induction of ferroptosis. Genes Dis. 10, 2195–2198 (2023).
Shum, M. et al. ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity. Sci. Transl. Med. 13, https://doi.org/10.1126/scitranslmed.abd1869 (2021).
Pulous, F. E. et al. MAT2A inhibition combats metabolic and transcriptional reprogramming in cancer. Drug Discov. Today 29, 104189 (2024).
Alam, A. & Locher, K. P. Structure and mechanism of human ABC transporters. Annu. Rev. Biophys. 52, 275–300 (2023).
Fuchs, C. D. et al. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice. Liver Int. 40, 1366–1377 (2020).
Yu, X. H. & Tang, C. K. ABCA1, ABCG1, and cholesterol homeostasis. Adv. Exp. Med. Biol. 1377, 95–107 (2022).
Cai, Q., Jing, C., Wang, X., Xing, X. & Liu, W. STEAP proteins: roles in disease biology and potential for therapeutic intervention. Int. J. Biol. Macromol. 309, 142797 (2025).
Abe, C., Miyazawa, T. & Miyazawa, T. Current use of fenton reaction in drugs and food. Molecules 27, https://doi.org/10.3390/molecules27175451 (2022).
Bafaro, E., Liu, Y., Xu, Y. & Dempski, R. E. The emerging role of zinc transporters in cellular homeostasis and cancer. Signal. Transduct. Target. Ther. 2, 17029 (2017).
Sahoo, G., Samal, D., Khandayataray, P. & Murthy, M. K. A review on caspases: key regulators of biological activities and apoptosis. Mol. Neurobiol. 60, 5805–5837 (2023).